Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K000586
    Date Cleared
    2000-07-03

    (132 days)

    Product Code
    Regulation Number
    862.1705
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    BIOSCANNER TRIGLYCERIDES TEST STRIPS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K991894
    Date Cleared
    2000-05-24

    (356 days)

    Product Code
    Regulation Number
    862.1705
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    BIOSCANNER TRIGLYCERIDES TEST STRIPS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BioScanner Triglycerides test strips are intended to measure triglyceride in whole blood as an aid in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction and other diseases involving lipid metabolism, or various endocrine disorders.

    Device Description

    Triglycerides are hydrolyzed by lipoprotein lipase to glycerol and fatty acid. Glycerol is phosphorylated by glycerol kinase in the presence of adenosine triphosphate (ATP) forming glycerol-3-phosphate and adenosine-5-diphosphate (ADP). The glycerol-3phosphate is oxidized by glycerophosphate oxidase to dihydroxyacetone phosphate and hydrogen peroxide. In the presence of peroxide, peroxidase catalyzes the coupling of 4-AAP (4-aminoantipyrine) with an N,N-disubstituted aniline to form a quinoneimine dye.

    AI/ML Overview

    I am sorry but the provided text does not contain detailed information about acceptance criteria, study methodologies, or specific performance metrics that would allow me to populate the requested table and answer all the questions about a study proving device acceptance. The document primarily focuses on the 510(k) submission, intended use, device description, and a comparison to a predicate device for substantial equivalence. It does not include a clinical study report or performance data against specific acceptance criteria.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1